Illumina | ILMN - Market Capitalization


Illumina reported $36.01B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 39.08B 6.43B Jun/2026
Bio-Rad Laboratories USD 7.87B 390M Jun/2026
Boston Scientific USD 63.6B 337M Nov/2026
Bruker USD 9.16B 3.66B Jun/2026
Charles River Laboratories USD 10.39B 2.54B Jun/2026
Danaher USD 157.81B 18.96B Sep/2026
Dentsply International USD 2.13B 191M Jun/2026
Edwards Lifesciences USD 52.09B 5.92B Jun/2026
Illumina USD 37.12B 3.64B Nov/2026
Intuitive Surgical USD 143.65B 2.81B Sep/2026
IQVIA Holdings USD 48.06B 3.81B Nov/2026
Laboratory Of America USD 24.99B 2.03B Sep/2026
Mettler Toledo International USD 25.82B 278M Jun/2026
OraSure Technologies USD 174M 61M Dec/2025
Pacific Biosciences Of California USD 565M 180M Dec/2025
Quest Diagnostics USD 25.72B 2.26B Sep/2026
Quidel USD 940M 66M Jun/2026
Repligen USD 10.85B 3.15B Sep/2026
Revvity USD 12.69B 2.75B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Standard Biotools USD 322M 37M Jun/2026
Thermo Fisher Scientific USD 249.58B 58.93B Sep/2026
Waters USD 37.24B 7.38B Jun/2026